Source of material
The synthesis of the title compound has been already described [1] . Crystals were obtained from a solution in hot ethanol.
Discussion
Nevirapine was the first non-nucleoside reverse transcriptase inhibitor (NNRTs) agent so far approved for clinical use in the treatment of AIDS and AIDS related complex (ARC). This compound assumes a "butterfly-like" spatial arrangement which well fits into the complementary allosteric cavity of HIV-1 reverse transcriptase [2] . Our studies on nevirapine analogues led us to discover pyrrolo[l,2-fc][l,2,5]benzothiadiazepine 5,5-dioxide derivatives (PBTDs), provided with potent anti-HIV-1 activities in vitro [3] . The butterfly-like configuration, depicted by the Schaefer's model, shows two aromatic hydrophobic moieties, connected as two wings by a linker, that are able to form a sterically favorable angle of 110°-115° between them [4] . We found recently that, when the amide bond N1-C7 is replaced by ester, the dihedral angle between the pyrrolyl and aryl moieties changes, in the crystal structure, to 86.7°, but molecular modeling studies showed that they can assume again a butterfly-like arrangement in the bioactive conformation [5] . The geometry of the bond distances and angles of the title compound does not show distortions, but the five-membered and sixmembered aromatic moieties adopt a dihedral angle of 118.4°, a value very near to that optimal for this compound class. This result led us to select the title compound as a lead for further optimization of this novel class of potent NNRT inhibitors and we started a computer-aided design of novel PBTDs. 
